The central role of SOCS-3 in integrating the neuro-immunoendocrine interface.
暂无分享,去创建一个
[1] E. Arzt. gp130 cytokine signaling in the pituitary gland: a paradigm for cytokine-neuro-endocrine pathways. , 2001, The Journal of clinical investigation.
[2] S. Melmed,et al. cAMP neuropeptide agonists induce pituitary suppressor of cytokine signaling-3: novel negative feedback mechanism for corticotroph cytokine action. , 2001, Molecular endocrinology.
[3] K. Nakao,et al. Induction of JAB/SOCS-1/SSI-1 and CIS3/SOCS-3/SSI-3 Is Involved in gp130 Resistance in Cardiovascular System in Rat Treated With Cardiotrophin-1 In Vivo , 2001, Circulation research.
[4] R. Unger,et al. The role of leptin resistance in the lipid abnormalities of aging , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[5] W. Leonard,et al. JAB/SOCS1/SSI-1 is an interleukin-2-induced inhibitor of IL-2 signaling. , 2001, Blood.
[6] J. Flier,et al. SOCS3 Mediates Feedback Inhibition of the Leptin Receptor via Tyr985 * , 2000, The Journal of Biological Chemistry.
[7] S. Melmed,et al. Direct regulation of pituitary proopiomelanocortin by STAT3 provides a novel mechanism for immuno-neuroendocrine interfacing. , 2000, The Journal of clinical investigation.
[8] J. Tavernier,et al. Identification of the Y985 and Y1077 motifs as SOCS3 recruitment sites in the murine leptin receptor , 2000, FEBS letters.
[9] S. Melmed,et al. Leukemia Inhibitory Factor Mediates the Hypothalamic Pituitary Adrenal Axis Response to Inflammation* * This work was supported by NIDDK Grants DK-54862-02 (to V.C.) and 501238 (to S.M.) and the Doris Factor Molecular Endocrinology Laboratory. , 2000, Endocrinology.
[10] M. Edery,et al. Potentiation of growth hormone-induced liver suppressors of cytokine signaling messenger ribonucleic acid by cytokines. , 2000, Endocrinology.
[11] C. Kedinger,et al. Role of suppressors of cytokine signaling ( Socs ) in leukemia inhibitory factor ( LIF )-dependent embryonic stem cell survival , 2000 .
[12] J. G. Zhang,et al. Suppressor of cytokine signaling-3 preferentially binds to the SHP-2-binding site on the shared cytokine receptor subunit gp130. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[13] S. Melmed,et al. Leukemia-inhibitory factor-neuroimmune modulator of endocrine function. , 2000, Endocrine reviews.
[14] Alexander S. Banks,et al. Activation of Downstream Signals by the Long Form of the Leptin Receptor* , 2000, The Journal of Biological Chemistry.
[15] S. Melmed,et al. Leukemia inhibitory factor mediates the hypothalamic pituitary adrenal axis response to inflammation. , 2000, Endocrinology.
[16] W. Leonard,et al. The Jak-STAT pathway. , 2000, Molecular immunology.
[17] S. Rivest,et al. Selective involvement of interleukin-6 in the transcriptional activation of the suppressor of cytokine signaling-3 in the brain during systemic immune challenges. , 2000, Endocrinology.
[18] R. Wilkins,et al. STAT5b mediates the GH-induced expression of SOCS-2 and SOCS-3 mRNA in the liver , 1999, Molecular and Cellular Endocrinology.
[19] D. Waxman,et al. SOCS/CIS Protein Inhibition of Growth Hormone-stimulated STAT5 Signaling by Multiple Mechanisms* , 1999, The Journal of Biological Chemistry.
[20] S. Melmed,et al. Inhibitory roles for SHP-1 and SOCS-3 following pituitary proopiomelanocortin induction by leukemia inhibitory factor. , 1999, The Journal of clinical investigation.
[21] J. Flier,et al. The Role of SOCS-3 in Leptin Signaling and Leptin Resistance* , 1999, The Journal of Biological Chemistry.
[22] A. Yoshimura,et al. Thrombopoietin induces an SH2-containing protein, CIS1, which binds to Mpl: involvement of the ubiquitin proteosome pathway. , 1999, Experimental hematology.
[23] P. Heinrich,et al. Different protein turnover of interleukin-6-type cytokine signalling components. , 1999, European journal of biochemistry.
[24] P. Kelly,et al. Inhibition and Restoration of Prolactin Signal Transduction by Suppressors of Cytokine Signaling* , 1999, The Journal of Biological Chemistry.
[25] J. Gustafsson,et al. Cis desensitizes GH induced Stat5 signaling in rat liver cells , 1999, Molecular and Cellular Endocrinology.
[26] P. Kelly,et al. Dual effects of suppressor of cytokine signaling (SOCS‐2) on growth hormone signal transduction , 1999, FEBS letters.
[27] S. Melmed,et al. Autoregulation of pituitary corticotroph SOCS-3 expression: characterization of the murine SOCS-3 promoter. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[28] S. Melmed,et al. Critical Role for STAT3 in Murine Pituitary Adrenocorticotropin Hormone Leukemia Inhibitory Factor Signaling* , 1999, The Journal of Biological Chemistry.
[29] S. Melmed,et al. Interleukin-11 stimulates proopiomelanocortin gene expression and adrenocorticotropin secretion in corticotroph cells: evidence for a redundant cytokine network in the hypothalamo-pituitary-adrenal axis. , 1999, Endocrinology.
[30] J. G. Zhang,et al. The conserved SOCS box motif in suppressors of cytokine signaling binds to elongins B and C and may couple bound proteins to proteasomal degradation. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[31] A. Yoshimura,et al. The JAK‐binding protein JAB inhibits Janus tyrosine kinase activity through binding in the activation loop , 1999, The EMBO journal.
[32] W. Alexander,et al. Mutational analyses of the SOCS proteins suggest a dual domain requirement but distinct mechanisms for inhibition of LIF and IL‐6 signal transduction , 1999, The EMBO journal.
[33] Y. Mao,et al. Endotoxin-induced inhibition of growth hormone receptor signaling in rat liver in vivo. , 1999, Endocrinology.
[34] K. Shuai,et al. The Suppressor of Cytokine Signaling (SOCS) 1 and SOCS3 but Not SOCS2 Proteins Inhibit Interferon-mediated Antiviral and Antiproliferative Activities* , 1998, The Journal of Biological Chemistry.
[35] C. Readhead,et al. Pituitary-directed leukemia inhibitory factor transgene causes Cushing's syndrome: neuro-immune-endocrine modulation of pituitary development. , 1998, Molecular endocrinology.
[36] F. Gouilleux,et al. A Sequence of the CIS Gene Promoter Interacts Preferentially with Two Associated STAT5A Dimers: a Distinct Biochemical Difference between STAT5A and STAT5B , 1998, Molecular and Cellular Biology.
[37] S. Melmed,et al. Pituitary corticotroph SOCS-3: novel intracellular regulation of leukemia-inhibitory factor-mediated proopiomelanocortin gene expression and adrenocorticotropin secretion. , 1998, Molecular endocrinology.
[38] S. Melmed,et al. Murine leukemia inhibitory factor gene disruption attenuates the hypothalamo-pituitary-adrenal axis stress response. , 1998, Endocrinology.
[39] S. Melmed,et al. Leukemia Inhibitory Factor Modulates Interleukin-1β-Induced Activation of the Hypothalamo-Pituitary-Adrenal Axis. , 1998, Endocrinology.
[40] J. Flier,et al. Identification of SOCS-3 as a potential mediator of central leptin resistance. , 1998, Molecular cell.
[41] D. Hilton,et al. Growth Hormone Preferentially Induces the Rapid, Transient Expression of SOCS-3, a Novel Inhibitor of Cytokine Receptor Signaling* , 1998, The Journal of Biological Chemistry.
[42] W. Alexander,et al. Twenty proteins containing a C-terminal SOCS box form five structural classes. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[43] S. Melmed,et al. Leukemia inhibitory factor modulates interleukin-1beta-induced activation of the hypothalamo-pituitary-adrenal axis. , 1998, Endocrinology.
[44] U. Ikeda,et al. SOCS-1/JAB/SSI-1 Can Bind to and Suppress Tec Protein-tyrosine Kinase* , 1997, The Journal of Biological Chemistry.
[45] D. Ray,et al. Cytokine-dependent gp130 receptor subunit regulates human fetal pituitary adrenocorticotropin hormone and growth hormone secretion. , 1997, The Journal of clinical investigation.
[46] Takaho A. Endo,et al. A new protein containing an SH2 domain that inhibits JAK kinases , 1997, Nature.
[47] Warren S. Alexander,et al. A family of cytokine-inducible inhibitors of signalling , 1997, Nature.
[48] A. Yoshimura,et al. CIS, a cytokine inducible SH2 protein, is a target of the JAK-STAT5 pathway and modulates STAT5 activation. , 1997, Blood.
[49] D. Ray,et al. A Common Pro-opiomelanocortin-binding Element Mediates Leukemia Inhibitory Factor and Corticotropin-releasing Hormone Transcriptional Synergy* , 1997, The Journal of Biological Chemistry.
[50] S. Melmed,et al. Leukemia inhibitory factor (LIF) induces acute adrenocorticotrophic hormone (ACTH) secretion in fetal rhesus macaque primates: a novel dynamic test of pituitary function. , 1996, The Journal of clinical endocrinology and metabolism.
[51] J. Ihle,et al. Naturally occurring dominant negative variants of Stat5 , 1996, Molecular and cellular biology.
[52] S. Melmed,et al. Hypothalamic and pituitary leukemia inhibitory factor gene expression in vivo: a novel endotoxin-inducible neuro-endocrine interface. , 1996, Endocrinology.
[53] S. Melmed,et al. Disrupted murine leukemia inhibitory factor (LIF) gene attenuates adrenocorticotropic hormone (ACTH) secretion. , 1996, Endocrinology.
[54] D. Ray,et al. Leukemia inhibitory factor (LIF) stimulates proopiomelanocortin (POMC) expression in a corticotroph cell line. Role of STAT pathway. , 1996, The Journal of clinical investigation.
[55] S. Melmed,et al. Human and murine pituitary expression of leukemia inhibitory factor. Novel intrapituitary regulation of adrenocorticotropin hormone synthesis and secretion. , 1995, The Journal of clinical investigation.